Shallcross Steven a, CEO and CFO at Synthetic Biologics, Inc. (SYN), bought 50,000 shares at $0.42 ($21K) on 2019-08-23, disclosed to the SEC on 2019-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TOVX | BUY | 2023-02-13 | $26K | — | Filing → |
| TOVX | BUY | 2023-02-03 | $24K | — | Filing → |
| TOVX | BUY | 2023-01-26 | $22K | — | Filing → |